1. Theophylline clearance in patients with asthma during concomitant administration of MY 5116 (repirinast);Asamoto H;Ther Res,1989
2. Pharmacokinetics of the active metabolite of the prodrug repirinast in healthy Caucasian volunteers after a single oral dose Eur J Clin;Beermann D;Pharmacol,1992
3. Determination of the active metabolite of the prodrug repirinast in human plasma by a liquid chromatography- tandem mass spectrometry method;Huang M;Latin Am J Pharm,2017
4. Studies on pharmacokinetics of MY-5116-3 Absorption, excretion and metabolism in man;Iwamoto A;Clin Rep,1986
5. Clinical evaluation of a new anti-allergic agent, MY-5116 for adult bronchial asthma Med. Consult;Miyamoto A;New Remed,1986